Authors:
KIRCHNER GI
FRANZKE A
BUER J
BEIL W
PROBSTKEPPER M
WITTKE F
OVERMANN K
LASSMANN S
HOFFMANN R
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: Gi. Kirchner et al., PHARMACOKINETICS OF RECOMBINANT HUMAN INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA PATIENTS FOLLOWING SUBCUTANEOUS APPLICATION, British journal of clinical pharmacology, 46(1), 1998, pp. 5-10
Authors:
SCHWAAB T
SCHNED AR
ATZPODIEN J
HEANEY JA
WITTKE F
ERNSTOFF MS
Citation: T. Schwaab et al., PHENOTYPE OF TUMOR-INFILTRATING DENDRITIC CELLS (TIDC) IN PATIENTS WITH RENAL-CELL CARCINOMA (RCC), The Journal of urology, 159(5), 1998, pp. 574-574
Authors:
FRANZKE A
PROBSTKEPPER M
BUER J
DUENSING S
HOFFMANN R
WITTKE F
VOLKENANDT M
GANSER A
ATZPODIEN J
Citation: A. Franzke et al., ELEVATED PRETREATMENT SERUM LEVELS OF SOLUBLE VASCULAR CELL-ADHESION MOLECULE-1 AND LACTATE-DEHYDROGENASE AS PREDICTORS OF SURVIVAL IN CUTANEOUS METASTATIC MALIGNANT-MELANOMA, British Journal of Cancer, 78(1), 1998, pp. 40-45
Authors:
MICHEL M
WITTKE F
MEYER O
FRANCES C
PIETTE JC
TOURNIERLASSERVE E
Citation: M. Michel et al., SCREENING FOR CHROMOSOME-1 SUSCEPTIBILITY LOCI AND GENES IN 125 LUPUSMULTIPLEX FAMILIES, Arthritis and rheumatism, 41(9), 1998, pp. 1262-1262
Authors:
ATZPODIEN J
KIRCHNER H
FRANZKE A
WANDERT T
PROBST M
BUER J
DUENSING S
WITTKE F
HOFFMANN R
GANSER A
Citation: J. Atzpodien et al., A RANDOMIZED CLINICAL-TRIAL COMPARING SC INTERLEUKIN-2, SC INTERFERON-ALPHA-2A, AND IV BOLUS B-FLUOROURACIL AGAINST ORAL TAMOXIFEN IN PROGRESSIVE METASTATIC RENAL-CELL CARCINOMA PATIENTS, European journal of cancer, 33, 1997, pp. 151-151
Authors:
FRANZKE A
PROBST M
BUER J
WITTKE F
HOFFMANN R
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: A. Franzke et al., AUTOIMMUNITY INDUCED BY INTERLEUKIN-2 AND INTERFERON-ALPHA IS ASSOCIATED WITH LONG-TERM SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, European journal of cancer, 33, 1997, pp. 163-163
Authors:
ATZPODIEN J
FRANZKE A
PROBSTKEPPER M
BUER J
VOLKENANDT M
WITTKE F
HOFFMANN R
GANSER A
Citation: J. Atzpodien et al., SOLUBLE VCAM-1 AS PREDICTOR OF SURVIVAL IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA, European journal of cancer, 33, 1997, pp. 1164-1164
Authors:
BUER J
PROBST M
FRANZKE A
DUENSING S
HAINDL J
VOLKENANDT M
WITTKE F
HOFFMANN R
GANSER A
ATZPODIEN J
Citation: J. Buer et al., ELEVATED SERUM LEVELS OF S100 AND SURVIVAL IN METASTATIC MALIGNANT-MELANOMA, British Journal of Cancer, 75(9), 1997, pp. 1373-1376
Authors:
HOFFMANN R
DUENSING S
SORGATZ M
GROSSE J
WITTKE F
GANSER A
ATZPODIEN J
Citation: R. Hoffmann et al., DYSREGULATION OF CYTOKINE-MEDIATED EXPRESSION OF INTERLEUKIN-1-BETA-CONVERTING ENZYME IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 90(10), 1997, pp. 1580-1580
Authors:
AUDRAN R
DRENOU B
WITTKE F
GAUDIN A
LESIMPLE T
TOUJAS L
Citation: R. Audran et al., INTERNALIZATION OF HUMAN MACROPHAGE SURFACE-ANTIGENS INDUCED BY MONOCLONAL-ANTIBODIES, Journal of immunological methods, 188(1), 1995, pp. 147-154